ctDNA Predicts Overall Survival in Patients With NSCLC Treated With PD-L1 Blockade or With Chemotherapy A next-generation sequencing–based cfDNA assay was used to profile 231 patients with mCRPC from ...
PTEN is one of the most commonly mutated tumor suppressor genes. It is an antagonist for many cellular growth, proliferation and survival processes. When mutated or deleted, it causes cancers of the ...
A collaboration between Saïd M. Sebti, Ph.D., chair of Moffitt Cancer Center's Drug Discovery Department, and Michele Pagano, M.D., chair of the Department of Biochemistry and Molecular Pharmacology ...
A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response critical for their elimination. Researchers at Baylor College of Medicine and ...
A common dietary supplement may help overcome mutations in the Pten gene. Should patients take it? By Gina Kolata When Kelley Oliver Douglass got breast cancer, a genetic counselor posed an odd ...
Bella Grambau has been told she is the only person in Australia and one of only a handful of people in the world with a rare ...
PTEN is one of the most commonly mutated tumor suppressor genes. It is an antagonist for many cellular growth, proliferation and survival processes. When mutated or deleted, it causes cancers of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results